ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001

Translucent Walls, Modern Classics Create “Corporate Feel” In Office Suite Occupied By Wife of MD Anderson President DePinho

May 24, 2013

Sanding Study Section For Cancer Control Grants Needed, Board Says

May 17, 1985

NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.

March 26, 2004

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

In Brief: NCAB To Protest Tobacco Ads In ‘Family Circle’; ACS Petitions For Taxol Source Designation

October 19, 1990